Subsequent Events - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended			12 Months Ended
	Jan. 16, 2021	Feb. 28, 2021	Jan. 31, 2021	Oct. 31, 2020	Dec. 31, 2020
Subsequent Event [Line Items]
Shares issued and sold				5,750,000
Public offering price per share				$ 23.50
Proceeds from public offering, net of underwriting discount				$ 135,100	$ 192,510
Net proceeds from sale of common stock				$ 126,600
Issuance of common stock from initial public offering, net of issuance costs					$ 188,323
Guide Therapeutics, Inc. | Merger Agreement
Subsequent Event [Line Items]
Merger agreement description					The Company paid Guide’s former stockholders and optionholders upfront consideration in an aggregate amount of $120.0 million, excluding customary purchase price adjustments, in shares of the Company’s common stock, based upon the volume-weighted average price of the Company’s common stock over the ten trading day period ending on February 19, 2021.
Milestone payment method, description					In addition, Guide’s former stockholders and optionholders will be eligible to receive up to an additional $100.0 million in technology and $220.0 million in product success milestone payments, payable in the Company’s common stock valued using the volume-weighted average price of the Company’s common stock over the ten trading day period ending two trading days prior to the date on which the applicable milestone is achieved.
Subsequent Event | Guide Therapeutics, Inc. | Merger Agreement
Subsequent Event [Line Items]
Payment of aggregate amount to stockholders and option holders upfront consideration excluding customary purchase adjustments		$ 120,000
Subsequent Event | Guide Therapeutics, Inc. | Merger Agreement | Technology | Maximum
Subsequent Event [Line Items]
Issuance of common stock from initial public offering, net of issuance costs		100,000
Subsequent Event | Guide Therapeutics, Inc. | Merger Agreement | Product Success Milestone Payments | Maximum
Subsequent Event [Line Items]
Issuance of common stock from initial public offering, net of issuance costs		$ 220,000
Private Placement | Subsequent Event
Subsequent Event [Line Items]
Shares issued and sold	2,795,700		2,795,700
Public offering price per share	$ 93.00		$ 93.00
Proceeds from public offering, net of underwriting discount	$ 260,000		$ 260,000
Net proceeds from sale of common stock	$ 252,100		$ 252,100